Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeEXECUTIVESMedtech Industry Veteran Hooman C. Hakami New Chairman of PathMaker Neurosystems BOD

Medtech Industry Veteran Hooman C. Hakami New Chairman of PathMaker Neurosystems BOD

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment of patients with serious neurological disorders such as stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI), has named Hooman C. Hakami as Chairman of the Company’s Board of Directors.  Mr. Hakami is currently the Managing Director of Hakami Healthcare Advisors, LLC where he provides advisory services to Boards and CEOs in the healthcare space.  Previously, he was with Medtronic, where he served as Executive Vice President and President of the Diabetes Group.

“I am delighted to have Hooman Hakami joining PathMaker as Chairman of the Board of Directors,” said Nader Yaghoubi, M.D., Ph.D., President and Chief Executive Officer of PathMaker. “As we approach commercialization, Hooman’s invaluable experience leading and operating global medtech companies will be an exceptional addition to our Board. I am confident his strategic insights will be instrumental as we take PathMaker to initial  regulatory approval next year on MyoRegulator®, the world’s first non-invasive neuromodulation device for the treatment of muscle spasticity.”

“I am pleased to be joining PathMaker.” Mr. Hakami commented. “The Company has the only non-invasive, multi-site neuromodulation system in the world.  This pioneering approach to treating neurological disease has the potential to bring about a new standard of care – through improved outcomes, lower cost and a better patient experience – for a number of serious conditions in urgent need of innovation, including Spasticity and ALS.  I look forward to helping guide the path of the Company.”

Mr. Hakami has 30 years of leadership experience, having been responsible for running multi-billion dollar businesses and managing thousands of employees on a global scale.  Prior to Medtronic, he spent more than 20 years at General Electric, where he was a Company Officer. There, he served as President and CEO of Detection and Guidance Solutions at GE Healthcare.  Prior to this he served as President and CEO of the Interventional Systems business based in France, and the Global Clinical Systems Services for GE Healthcare.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy